FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to-severe Sjögren’s disease, which could be the first targeted therapy ever ...
Ava Chambers, 19, from Ohio, was just 14 when her health rapidly began deteriorating following a mild case of Covid. It took ...
In 2024, researchers launched the EXTEND-IT project to design and prepare a study on a physical activity intervention for children at risk of Type 1 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback